Triparna Sen: Improving outcomes for patients with small cell lung cancer
Triparna Sen shared on LinkedIn:
“Feeling incredibly grateful to have received this thoughtful bracelet from SclcSMASHERS —a group that does so much for patients with SCLC and their families.
2024 was a year of tremendous progress for Small Cell Lung Cancer:
Advances in understanding its biology, biomarkers, and potential targets
New clinical developments bringing hope to patients, but there’s still so much more work to be done and my group at Icahn School of Medicine at Mount Sinai is focused on improving outcomes for patients with small cell lung cancer.
Fondly remember the inspiring Facebook Live with Misty Shields, SclcSMASHERS, Upal Basu Roy of LUNGevity Foundation. It’s conversations like these that remind us why we keep pushing forward.
Here’s to continued teamwork, innovation, and impact in 2025!”
Dr. Triparna Sen is an Associate Professor, in the Department of Oncological Sciences, and the Director of the Lung Cancer PDX Platform at the Icahn School of Medicine at Mount Sinai, New York. She leads a multi-disciplinary team of investigators in laboratory-based, patient-focused investigations focused on cancer biology and precision medicine
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023